PTEN
deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome
Keyword(s):
2014 ◽
Vol 184
(3)
◽
pp. 609-617
◽
Keyword(s):
Keyword(s):